Lijia Luo
- Biomedical Engineering top 5%
- Materials Chemistry top 10%
- Molecular Biology
- Biomaterials top 5%
- Immunology
- Co-authors
- Aiguo WuChuang LIUJie XingOzioma Udochukwu AkakuruZhangsen YuQianlan FangShan SunRuifen Zou
- Topics
- Nanoplatforms for cancer theranostics (10 papers)Nanoparticle-Based Drug Delivery (6 papers)Immunotherapy and Immune Responses (5 papers)
- Journals
- Nano LettersACS NanoBiomaterials
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Lijia Luo
19 papers receiving 891 citations
Peers
Comparison fields: 5 of 73
- Biomedical Engineering 599
- Materials Chemistry 445
- Molecular Biology 247
- Biomaterials 211
- Immunology 149
Countries citing papers authored by Lijia Luo
This map shows the geographic impact of Lijia Luo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lijia Luo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lijia Luo more than expected).
Fields of papers citing papers by Lijia Luo
This network shows the impact of papers produced by Lijia Luo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lijia Luo. The network helps show where Lijia Luo may publish in the future.
Co-authorship network of co-authors of Lijia Luo
This figure shows the co-authorship network connecting the top 25 collaborators of Lijia Luo. A scholar is included among the top collaborators of Lijia Luo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lijia Luo. Lijia Luo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 12 | |
| 3 | 1 | |
| 4 | 8 | |
| 5 | 12 | |
| 6 | 68 | |
| 7 | 51 | |
| 8 | 13 | |
| 9 | 19 | |
| 10 | 9 | |
| 11 | 89 | |
| 12 | 302 | |
| 13 | 91 | |
| 14 | 2 | |
| 15 | 40 | |
| 16 | 54 | |
| 17 | 19 | |
| 18 | 34 | |
| 19 | 67 | |
| 20 | 3 |
About Lijia Luo
Lijia Luo is a scholar working on Biomaterials, Biomedical Engineering and Immunology, having authored 20 papers that have together received 894 indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (10 papers), Nanoparticle-Based Drug Delivery (6 papers) and Immunotherapy and Immune Responses (5 papers). The work is most often cited by research in Biomaterials (211 citations), Biomedical Engineering (599 citations) and Materials Chemistry (445 citations). Lijia Luo has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Aiguo Wu, Chuang LIU, Jie Xing, Ozioma Udochukwu Akakuru, Zhangsen Yu, Qianlan Fang, Shan Sun, Ruifen Zou, André E. Nel and Yu‐Pei Liao. Their work appears in journals such as Nano Letters, ACS Nano and Biomaterials.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.